Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGCP Infrastructure Investments Regulatory News (GCP)

Share Price Information for GCP Infrastructure Investments (GCP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.90
Bid: 77.90
Ask: 78.10
Change: 0.00 (0.00%)
Spread: 0.20 (0.257%)
Open: 79.80
High: 79.80
Low: 77.70
Prev. Close: 77.90
GCP Live PriceLast checked at -
GCP Infrastructure Investments is an Investment Trust

To provide shareholders with regular, sustainable, long-term dividend income and to preserve the capital value of its investments over the long term by generating exposure to infrastructure debt and/or similar assets.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GCP Applied Technologies Receives European Patent on Sustainable Cement Grinding Methods

18 Oct 2018 11:00



GCP Applied Technologies Receives European Patent on Sustainable Cement Grinding Methods

Bio-derived Solutions Enhance Efficiency of Cement Grinding and Reduce CO2 Emissions

CAMBRIDGE, Mass., Oct. 18, 2018 (GLOBE NEWSWIRE) -- GCP Applied Technologies Inc. (NYSE:GCP), a leading global provider of construction products technologies, is proud to announce the issuance of a patent for increasing the efficiency of cement grinding by using sustainable raw materials. The novel grinding aids and quality improvers allow the use of bio-derived glycerol and reduce the use and the impact of oil-derived chemicals.

This development continues GCP Applied Technologies’ commitment to offer cement producers a complete portfolio of products and services, enabling them to lead in cement quality, cost efficiency and sustainability. The new OPTEVA™ and TAVERO™ cement additives enable cement producers to reduce the energy consumption and the CO2 emissions associated with cement production, with a reduced use, or no use at all, of oil-derived chemicals.

“GCP Applied Technologies is focused on meeting the demands of modern cement plants,” said Dave Myers, vice president R&D and technical support. “We are committed to continuing research and development to improve cement additive products with innovative materials and services. GCP offers cement producers a complete portfolio of solutions that yield more sustainable cement production with enhanced quality and improved cost efficiency.”

European Patent No. EP 1 728 771 B1 has been granted and registered into seventeen European countries. The patent addresses methods for increasing the efficiency of cement and mineral grinding by using sustainable raw materials.

The patent relates to methods for improving the efficiency of grinding materials such as clinker and limestone, using glycerol derived from biofuel production, in combination with various grinding additives. GCP products can help shrink the carbon footprint of cement and concrete. Grinding aids and quality improvers make cement manufacturing more efficient, while concrete admixtures can reduce the amount of cement needed to achieve a given strength specification.

The company continues to expand its comprehensive portfolio of additives for cement production with high-performing quality improvers under the OPTEVA™ brand and innovative grinding aids under the TAVERO™ brand. 

Media RelationsPaul KeeffeT +1 617.498.4461mediainfo@gcpat.comInvestor RelationsJoseph DeCristofaroT +1 617.498.2616investors@gcpat.com

About GCP Applied Technologies

GCP is a leading global provider of construction products technologies that include additives for cement and concrete, the VERIFI® in-transit concrete management system, high-performance waterproofing products, and specialty systems. GCP products have been used to build some of the world’s most renowned structures. More information is available at www.gcpat.com.

This announcement contains “forward-looking statements,” that is, information related to future, not past, events. Such statements generally include the words “believes,” “plans,” “intends,” “targets,” “will,” “expects,” “suggests,” “anticipates,” “outlook,” “continues,” or similar expressions. Forward-looking statements include, without limitation, statements about expected financial positions; results of operations; cash flows; financing plans; business strategy; operating plans; capital and other expenditures; competitive positions; growth opportunities for existing products; benefits from new technology and cost reduction initiatives, plans and objectives; and markets for securities. Like other businesses, GCP is subject to risks and uncertainties that could cause its actual results to differ materially from its projections or that could cause other forward-looking statements to prove incorrect. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, risks related to: the cyclical and seasonal nature of the industries that GCP serves; foreign operations, especially in emerging regions; changes in currency exchange rates; the cost and availability of raw materials and energy; the effectiveness of GCP’s research and development, new product introductions and growth investments; acquisitions and divestitures of assets and gains and losses from dispositions; developments affecting GCP’s outstanding liquidity and indebtedness, including debt covenants and interest rate exposure; developments affecting GCP’s funded and unfunded pension obligations; warranty and product liability claims; legal proceedings; the inability to establish or maintain certain business relationships and relationships with customers and suppliers or the inability to retain key personnel; and the handling of hazardous materials and the costs of compliance with environmental regulation. These and other factors are identified and described in more detail in GCP's Annual Report on Form 10-K, which has been filed with the U.S. Securities and Exchange Commission and is available online at www.sec.gov. Readers are cautioned not to place undue reliance on GCP’s projections and forward-looking statements, which speak only as the date thereof. GCP undertakes no obligation to publicly release any revision to the projections and forward-looking statements contained in this announcement, or to update them to reflect events or circumstances occurring after the date of this announcement.


Date   Source Headline
27th Mar 20183:26 pmRNSRevolving Credit Facility
21st Mar 20182:44 pmRNSNew Directorship Notification
28th Feb 20187:00 amRNSTotal Voting Rights
27th Feb 201812:24 pmRNSDirector/PDMR Shareholding
23rd Feb 20183:47 pmRNSDirector/PDMR Shareholding
23rd Feb 20188:15 amRNSAdditional Listing
22nd Feb 20189:32 amRNSFirst Priority Housing Association
16th Feb 20187:00 amRNSAdditional Listing
9th Feb 201812:30 pmRNSResults of the AGM and EGM
1st Feb 20181:57 pmRNSScrip Share Reference Price
31st Jan 20187:00 amRNSTotal Voting Rights
29th Jan 20187:00 amRNSInvestment Commitment of c.£105 million
23rd Jan 20182:04 pmRNSDirector/PDMR Shareholding
22nd Jan 20187:00 amRNSInvestor Report as at 29 December 2017
19th Jan 20187:00 amRNSDividend Declaration & Scrip Dividend Alternative
17th Jan 20183:02 pmRNSTotal Voting Rights
12th Jan 20187:00 amRNSPlacing under Placing Programme
9th Jan 20187:00 amRNSNet Asset Value(s)
8th Jan 20185:41 pmRNSNotice of AGM & EGM
8th Jan 20183:21 pmRNSPublication of Supplementary Prospectus
8th Jan 20187:00 amRNSPlacing under Placing Programme
19th Dec 20177:00 amRNSMarkets in Financial Instruments Directive
14th Dec 20177:00 amRNSAnnual report and financial statements
7th Dec 20177:00 amRNSDirector/PDMR Shareholding
4th Dec 20173:48 pmRNSDirector/PDMR Shareholding
1st Dec 20179:18 amRNSAdditional Listing and Total Voting Rights
30th Nov 20177:00 amRNSRefinancing of investment
28th Nov 20177:00 amRNSRevolving Credit Facility
22nd Nov 20177:00 amRNSAdditional Listing
15th Nov 20179:26 amRNSConditional investment commitment
3rd Nov 201711:55 amRNSScrip Dividend Circular
30th Oct 20172:53 pmRNSInvestor Report as at 30 September 2017
19th Oct 20172:38 pmRNSDividend Declaration
11th Oct 201712:24 pmRNSNet Asset Value(s)
29th Sep 20177:00 amRNSTotal Voting Rights
20th Sep 20174:53 pmRNSDirector/PDMR Shareholding
15th Sep 201710:13 amRNSAdditional Listing & Total Voting Rights
6th Sep 20174:51 pmRNSAdditional Listing
4th Sep 20177:00 amRNSNew Website
29th Aug 20173:20 pmRNSDirector/PDMR Shareholding
25th Aug 20171:48 pmRNSNotification of Major Interest in Shares
18th Aug 20173:29 pmRNSSCRIP Dividend Circular
18th Aug 20177:39 amRNSInvestment commitment of c.£140 million
8th Aug 201710:46 amRNSNew directorship notification
2nd Aug 20172:09 pmRNSInvestor Report 30 June 2017
28th Jul 201711:50 amRNSDividend Declaration & Scrip Dividend Alternative
24th Jul 20177:00 amRNSNet Asset Value(s)
21st Jul 20174:13 pmRNSNotification of Major Interest in Shares
18th Jul 201712:04 pmRNSTotal Voting Rights
14th Jul 20177:00 amRNSPlacing under Placing Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.